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score is equal or greater than 62 points (sensitivity: 89.6%, speciﬁcity: 83.8%), and
BNP is from 509.86 to 1091.42 pg/ml. Besides, the results of retrospective and
prospective clinical assess showed all of the sensitivity, speciﬁcity and accuracy
degree were above 90%, and positive likelihood ratios were almost greater than 10.
Conclusions: The clinical diagnosis criteria of qi-yin-deﬁciency syndrome and yang-
deﬁciency-water-overﬂowing syndrome divide symptoms and signs into major and
minor deﬁning characteristics, by considering the variation of BNP. It has higher
sensitivity, speciﬁcity and accuracy, which can be better applied in clinical practice.
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A prospective, single-blind, randomized, controlled and multicenter clinical trial
of standardized Western therapy alone or combined with traditional Chinese
medication staging-differentiation treatment in patients with chronic heart
failure: Results of the SECETCM-HF
Xianliang Wang, Jingyuan Mao
Cardiovascular Department of the First Teaching Hospital of Tianjin University of
Traditional Chinese Medicine
Objectives: To compare the efﬁcacy of standardized western therapy alone and
combined with traditional Chinese medication staging-differentiation treatment in
patients with chronic heart failure (CHF).
Methods: In total, 340 CHF patients aged 40-79 years were randomized into control or
treatment groups on admission. The trial included three periods of intervention and
comprehensive evaluation. During the hospitalization, the control group received stan-
dard medication plus a polarized solution. Patients in the treatment group also received a
Shenfu injection for qi-yang deﬁciency or a Shenmai injection for qi-yin deﬁciency along
with a Danhong injection. After the discharge, all patients were continually treated with
standardized medication plus the study drugs (Qiliqiangxin capsule for qi-yang deﬁ-
ciency and Buyiqiangxin tablets for qi-yin deﬁciency) or a placebo for 6 months. After
6 month visits, both groups received the standard medication alone.
Results: On discharge, the treatment group showed greater improvement in the six-
minute walk test (6MWT; P<0.05) compared with the control group. After 12 months
of follow-up, there was a time-group interaction for Minnesota Living with Heart
Failure Questionnaire (MLHFQ) (P¼0.03). The K-M curves for the cumulative sur-
vival rate showed no signiﬁcant difference between the two groups (P¼0.208), but the
treatment group tended to have better survival. The adverse events and safety proﬁle
of the interventions were similar in the two groups (P>0.05).
Conclusions: Standardized medication plus TCM staging-differentiation treatment
improves cardiopulmonary function and quality of life and have tend to increases the
survival rate.
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The effect of different altitude hypoxia on hemin oxygenase (HO) -1/CO-bilirubin
system in elderly patients with congestive heart failure
Xi Aiqi, Zhong Xin, Liao Bao-Xia, Li Guo-Feng, Tang Xiaolan
Geriatrics Department, The People’s Hospital of Qinghai Province, Xining, Qinghai
Objectives: High altitude (HA) presents inhospitable environmental conditions that
adversely affects human physiology and metabolism. Changes in physiological
functions are reported during high altitude exposure. yet, Few study have explored the
effect of different altitude hypoxia (2260 m, 3300-3500 m) on hemin oxygenase (HO)
-1/CO-bilirubin system in elderly patients (65 years old) with congestive heart
failure, and to evaluate the relationship with left ventricular mass index (LVMI), mean
wall stress (MWS) and cardiac function.
Methods: CHF patients (n¼56) from high altitude were studied and 69 CHFs from
moderate altitude (2260 m) were enrolled as controls, the serum levels of heme oxy-
genase-1 (HO-1), carbox yhemoglobin (COHb) were detected. Their Left ventricular
ejection fraction (LVEF) LVMI and MWS were measured by echocardiography.
Results: Compared with moderate altitude group, the serum levels of HO-1 and
COHb were obviously increased in high altitude group[HO-1 (127.812.8) vs
(86.58.4) nmol/h.L; COHb (9.431.36) % vs (5.270.75) %respectively]. Simi-
larly, LVMI and MWS were signiﬁcantly higher in high altitude group [(182.38.7)
vs (98.45.3) g/m2 and (453.815.7) vs (299.410.1) dynes x103/cm2, respectively].
there was a positive correlation between LVMI, MWS and the levels of HO-1, COHb
(all P<0.01).
Conclusions: With the increase of altitude, CHF patients had higher levels of HO-1,
COHb. the unbalance of oxidation/ antioxidation pay important roles in pathophysio-
logical and pathogeneticmechanism of ventricular remodeling in CHF from high altitude.
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To evaluate the effect of PCI in the patients who get the anterior myocardial
infarction with ventricular aneurysm and the change of N-terminal B-type
natriuretic peptide (BNP), serum high-sensitivity C-reactive protein (hs-CRP),
and analysis of the aneurysm patients in perioperative period of PCI TCM
syndrome type changes that can be used
Wang Xianghe, Zhang Ting, Cao Xuebin
The 252nd Hospital of PLA
Objectives: To evaluate the effect of PCI in the patients who get the anterior
myocardial infarction with ventricular aneurysm and the change of N-terminal B-typeC186 JACC Vol 64/16/Suppl C j October 16–1natriuretic peptide (BNP), serum high-sensitivity C-reactive protein (hs-CRP) in
perioperative period of PCI, and whether these factors could be early predictors of
ventricular aneurysm. Finally analysis of the aneurysm patients in perioperative period
of PCI TCM syndrome type changes that can be used, conditioning, the Integrative
inhibition of ventricular remodeling.
Methods: 43 cases with anterior myocardial infarction who underwent PCI, including
31 males and 12 females, average aged 58.312.1 (55-69) years old; previous PCI,
severe infection, tumors, rheumatic diseases, infectious disease, liver and renal
insufﬁciency excluded. Based on left ventricular angiography, the patients were
divided into ventricular aneurysm group and control group. All patients were got the
blood serum sample of hs-CRP, BNP before PCI, and hs-CRP 12-16 h or serum BNP
after 48 h. Ultrasonic cardiogram, ECG, serum proBNP and hs-CRP were followed up
in one month. First of all, according to EF and left ventricular internal diameter of
1 month after surgery in the ventricular aneurysm group, 25 people conﬁrmed the
signiﬁcance of the PCI in ventricular aneurysm in patients. Followed by between
ventricular aneurysm groups and control groups compare hs-CRP preoperative and
postoperative 12-16 h, BNP preoperative postoperative 48 h and after one month,
making a comparison conﬁrmed that hs-CRP and BNP for ventricular aneurysm in
patients undergoing PCI of the predictive value.
Results: (1) Compared pre-PCI and 48 h after PCI in Ventricular aneurysm group, the
LVEF (Left ventricular eject fraction, LVEF; 0.5470.101 vs 0.5650.092,
P¼0.513>0.05) and LVEDD (left ventricular diastolic diameter, LVEDD;
52.526.838 vs 50.845.720, P¼0.351 >0.05) were not signiﬁcant difference. But
there were signiﬁcant difference of LVEF (0.5470.101 vs 0.6020.072, P¼0.031
<0.05) and LVEDD (52.526.838 vs 47.164.119, P¼0.002 <0.05) between pre-
PCI and one month after PCI. (2) Compared to Control group, serum hs-CRP pre-
operative, postoperative 12-16h in the ventricular aneurysm group were signiﬁcant
increase (3.50 (1.37-12.38) vs 0.98 (0.27-5.10), 3.12 (1.85-9.41) vs 1.11 (0.21-3.33),
P value were 0.012 and 0.01). Serum NT-proBNP pre-PCI, 48 h and a month after PCI
in the ventricular aneurysm group were signiﬁcant difference (1173.00 (518.75-
198.50) vs 439.30 (123.33-912.83), 1008.00 (625.70-1914.50) vs 331.05 (138.75-
781.08), 658.00 (498.00-1184.00) vs 349.00 (114.25-534.00), P value ¼0.013, 0.01,
0.003). (3) Preoperative TCM, more than 43 cases of patients with anterior myocardial
infarction and blood deﬁciency, blood stasis - based PCI postoperative Qi Deﬁciency,
blood stasis, heart yang lack of permit, Qi blood stasis and heat toxin attacks the card,
liver and spleen do not tune the card.
Conclusions: (1) PCI can improve heart function to anterior myocardial infarction
with Left ventricular aneurysm patients. (2) Serum hs-CRP and NT-proBNP maybe
predictive value for anterior myocardial infarction with Left ventricular aneurysm
patients. (3) 43 cases of patients before surgery, TCM Integrative conditioning the
patients, which will help patients with early rehabilitation.
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Xinshuitong Capsule via aquaporin-2 enhances Xinshuitong Capsule via
aquaporin-2 enhances the diuretic effect in the chronic heart failure patients
Tan Chunjiang1, Xiao Lu1, Chen Songming2
1Fujian University of Traditional Chinese Medicine, 2The First Afﬁliated Hospital of
Shantou University
Objectives: Aquaporin-2 (AQP-2), which was involved in renal water reabsorption,
was found high in the urine of chronic heart failure (CHF) patients. Xinshuitong
Capsule (XC) has natriuretic effect in CHF patients, however, whether this effect
related to AQP pathway remains unclear.
Methods: 36 NYHA IIand III CHF patients were randomized into three groups:
routine therapy (RT), routine therapy plus XC (RX) or plus placebo (RP), all the
patients received furosemide treatment (60 mg/d). Quality of life (QL) was assessed
by SF-36 Health Status Survey. Urine AQP-2, 24 h urine volume, free water clearance
(CH2O) and fractional excretion of sodium (FENa), plasma vasopressin (AVP), renin,
angiotensin II (Ang II), aldosterone (Aldo), atrial (ANP) and brain natriuretic peptides
(BNP) were measured before or every day in the 15-day study.
Results: The groups were matched for age, gender, race, baseline indexes, and NYHA
class stratiﬁcation. Compared to RT or RP group, urinary AQP-2 excretion decreased
in RX group from day 2, and the signiﬁcant decrease was observed at day 6 and
this level maintained until the end of the study (pmol / ml: day0, 9221; day 1,
7213; day 2, 5510; day 3, 4411; day 4, 3511; day 5, 227; day 6, 155; day 6
vs. day 0, P<0.05). CH2O lower in RX compared to RT or RP. Plasma levels of AVP
(20%), renin (12%), Ang II (9%) and Aldo (17%) were lower in RX compared to RT
and RP, however, plasma levels of ANP and BNP showed no difference among the
three groups. QL and NYHA class in RX improved in varying degrees compared with
the other two groups.
Conclusions: XC could increase urine output and inhibit water reabsorption via the
APQ2 water channel, and XC also had pharmacodynamic actions on AVP and the
renin-angiotensin-aldosterone system and synergistically enhanced natriuretic effects
in CHF patients.
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Research on Diagnosis Criteria of Qi-deﬁciency-blood-stasis Syndrome of
Congestive Heart Failure Based on Literature Analysis, Clinical Retrospective
Analysis, and Epidemiological Survey
He Jiancheng, He Jiancheng, Li Xiaoqian, Huang Pinxian
Shanghai University of T.C.M9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
Objectives: To discuss the clinical rules of TCM four diagnostic information and
relevant indicators in qi-deﬁciency-blood-stasis syndrome of congestive heart failure,
and consummate diagnosis criteria of the syndrome.
Methods: (1) Based on databases of CNKI (1980-2012) and VIP (1989-2012), related
modern literatures on CHF were reorganized and analyzed, and syndrome factors were
extracted from them. The pathogenesis and common syndromes of this disease got
analysized. (2) 1694 CHF cases from grade 3 and ﬁrst-class hospitals (from Dec, 2010
to Sep, 2012) were collected, with rank sum test, Spearman rank correlation analysis
and factor analysis by SPSS18.0. The correlations in qi-deﬁciency-blood-stasis syn-
dromes and age, sex, primary illnesses, lab index, major and minor symptoms had
been studied. (3) 750 CHF cases from multicenter (from Dec, 2012 to Dec, 2013) were
collected by applying TCM syndrome scale of congestive heart failure. The threshold
values in clinic diagnosis of qi-deﬁciency-blood-stasis syndrome got determined by
applying maximum likelihood method combined with ROC curve. The manifestations
of tongue and pulse got analysized by logistic regression. Reference range of BNP
also got described by the mean value and median.
Results: (1) Literature analysis indicates: Syndrome factors on disease location of
CHF are the heart, kidney, lung, and the spleen. Factors on natures of this disease
sorted from more to less is qi deﬁciency, blood stasis, yang deﬁciency, yin deﬁciency,
yang exhausted, water retention, etc. The pathogenesis of CHF mainly is deﬁciency
complicated with excess, and qi-deﬁciency-blood-stasis syndrome is the common
pattern of this disease. (2) Retrospective analysis of clinical cases indicates: There are
367 cases of qi-deﬁciency-blood-stasis syndrome in 1694 CHF cases. It mostly can be
seen in male patients aged 50-70 and female patients aged over 70 years old. The
primary disease mainly is coronary heart disease. And it also has correlation with
BNP. The major symptoms of it are chest suppression, palpitation, short breath, dark-
red tongue, white fur and thin pulse. The minor one is thin fur. (3) Syndrome scale
analysis showed: The diagnosis criteria of CHF qi-deﬁciency-blood-stasis syndrome is
total score of related items is equal or greater than 76 points (sensitivity: 96.9%,
speciﬁcity: 86.9%). The results of retrospective and prospective clinical assess showed
the sensitivity and speciﬁcity was above 90%. The common manifestations of tongue
and pulse are purple tongue with petechia and uneven pulse. And the reference range
of BNP is from 209.33 to 316.57 pg/ml.
Conclusions: The essential syndrome of congestive heart failure is qi-deﬁciency
-blood-stasis syndrome. The clinical distribution links to patients’ age and gender.
Congestive heart failure mostly develops from coronary heart disease. The syndrome
scale of CHF has higher sensitivity and speciﬁcity, which is available to the clinical
application.
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Decreased plasma relaxin-3 levels in patients with chronic heart failure
Zhang Xiaohui, Yin Xinhua
The Department of Cardiology, The First Afﬁliated Hospital of Harbin Medical
University, Harbin, China
Objectives: Relaxin-3 has been found to alleviate isoproterenol-induced myocardial
ischemia injury and have anti-ﬁbrotic action. The role of endogenous relaxin-3 on
chronic heart failure (CHF), however, remains unknown.
Methods: We investigated the levels of plasma relaxin-3 and their relationship to
cardiovascular function in patients with CHF. We studied 31 patients who were
admitted with CHF that was caused by left ventricular systolic dysfunction [New York
Heart Association (NYHA) functional class III or IV] and 38 age-matched healthy
subjects. Blood samples were taken at study entry, and the relaxin-3, relaxin-2 and N-
terminal pro-brain natriuretic peptide (NT-pro BNP) were measured. Cardiac structure
and function were measured by echocardiography.
Results: Relaxin-3 levels were signiﬁcantly lower in CHF patients than in controls:
the median plasma relaxin-3 concentration was 57.41 pg/ml (range, <49.56-64.42 pg/
ml) in patients with CHF and 69.37 pg/ml (range, <63.90-72.97 pg/ml) in controls
(P<0.001). However, no differences in relaxin-2 levels were observed between the
CHF group and controls (P¼0.505). The plasma levels of relaxin-3 positively
correlated with total cholesterol (r¼0.39, P¼0.032) and NT-pro BNP (r¼0.39,
P¼0.032) in patients with CHF. Plasma relaxin-3 concentration showed no statisti-
cally signiﬁcant associations with other component traits in patients with CHF.
Additionally, there was no correlation between the plasma concentrations of relaxin-3
and relaxin-2 in patients with CHF (r¼-0.25; P¼0.174).
Conclusions: We conclude that plasma relaxin-3 concentrations are decreased in
CHF, though low endogenous relaxin-3 levels are only related to total cholesterol and
NT-pro BNP.
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Diagnostic and predictive value of serum galectin-3 in patients with chronic heart
failure
Geng Fanqi, Yang Ping
China-Japan Union Hospital of Jilin University
Objectives: Biological markers such as BNP and NT-proBNP have been widely used
in evaluation of the incidence and severity of heart failure clinically. However,
multiple mechanisms are involved in the pathophysiology process of heart failure,
thus, a single marker may not be sufﬁcient. Combination of several biological markers
may be more reliable. Galectin-3 is a new biological marker, which may participate inJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cthe regulation of cardiac ﬁbrosis and remodling. Therefore, it can be used in evalu-
ation of the incidence and severity of HF, it can also be used to predict prognosis in
patients with HF. In this study comparison of the level of serum galectin-3 in CHF and
Control, correlation analysis between the level of serum galectin-3 and LA, LVD,
LVEF and BNP in chronic heart failure were invested. Analyse and discuss the sig-
niﬁcance of serum galectin-3 in chronic heart failure. And compare of the diagnositic
value of Galectin-3 and BNP for CHF in both the sensitivity and speciﬁcity.
Methods: Patients with chronic heart failure were recruited. The signiﬁcance of heart
failure was determined by NYHA classiﬁcation II-IV. The level of serum galectin-3
was determined by sandwich ELISA. Echocardiography was performed to determine
the diastolic left atrial diameter (LA), left ventricular end-diastolic diameter (LVD)
and left ventricular ejection fraction (LVEF). Data were analyzed by SPSS 17.0,
P<0.05 was considered statistically signiﬁcant. Association of two sets of data was
evaluated with Pearson correlation analysis. Receiver-operating characteristic (ROC)
curve was used to analyze the prognostic value of galectin-3 or BNP for CHF.
Results: The level of serum galectin-3 was signiﬁcantly higher in the CHF group
compared with that in control; The differences of the level of serum galectin-3 be-
tween diffrernt sub-groups was statistically signiﬁcant (P<0.05 and P<0.01). The
level of serum galectin-3 was positively correlated with LA (r¼0.465, P<0.01) and
LVD (r¼0.643, P<0.01), but negatively correlated with LVEF (r¼-0.788, P<0.01).
The level of plasma BNP was positively correlated with LA (r¼0.464, P<0.01) and
LVD (r¼0.633, P<0.01), but negatively correlated with LVEF (r¼-0.799, P<0.01).
The level of serum galectin-3 was positively correlated with the level of plasma BNP
(r¼0.855, P<0.01). AUC was 0.808 when the level of serum galectin-3 was more than
8.61 ng/ml. The sensitivity to predict CHF was 77.1%, the speciﬁcity was 92.3%.
AUC was 0.903 when the level of plasma BNP was more than 1011 pg/ml. The
sensitivity to predict CHF was 81.6% and the speciﬁcity was 90.3%.
Conclusions: (1) The level of serum galectin-3 is related to the changes of left heart
structure and function, indicating that galectin-3 may be involved in the process of left
ventricular remodeling in CHF. (2) The speciﬁcity of galectin-3 is higher than BNP in
predicting CHF, not the sensitivity.
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Observation of effects of individualized rehabilitation guidance on patients with
heart failure after myocardial infarction
Gong Shuang, Liu Yue, Yang Bin
The ﬁrst Hospital of Jilin University
Objectives: To explore the inﬂuence of individualized rehabilitation guidance for
improving heart function in patients with heart failure after myocardial infarction.
Methods: Enroll 106 hospitalized patients with heart failure after myocardial
infarction in the study, 52 male, 54 female, aging from 68 to 75, cardiac function
ranging from II to III levels. they all suffered from heart failure after myocardial
infarction and were treated with strong heart diuresis therapy. All 106 cases were
randomly divided into two groups (control group and vs. observation group), there
was no statistically signiﬁcant difference between them. Patients in control group were
treated with routine nursing care during hospital stay, while for patients in the
observation group, In addition to routine nursing instruction, individualized rehabil-
itation guidance was performed, including the rest and activity guidance, diet guid-
ance, defecation guidance, medication guidance, psychological guidance, guidance of
disease knowledge, and self-monitoring, et al. A 6 months follow-up was conducted
after discharge. The monitoring indicators including 6 minutes walking dis-
tance, B-type natriuretic peptide. heart function in hospital and 6 months after
hospitalization.
Results: 6 minutes walking distance in observation group increased signiﬁcantly than
the control group, the difference was statistically signiﬁcant (P<0.05). The level of
B-type natriuretic peptide decreased in 49 cases in the observation group, and in the
control group that was 42, the differences was statistically signiﬁcant (P<0.05).
Conclusions: Individualized inpatient rehabilitation guidance can help the patients
build up a good way of life, ensure the treatment effect, improve the patient’s heart
function and life quality.
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Change of the level of plasma homocysteine in patients with dilated
cardiomyopathy
Li Juxiang, Liao Chunyao, Zhen Xia, Jianhua Yu, Hong Kui, Xiaoshu Cheng
Department of Cardiovascular Medicine, The Second Afﬁliated Hospital to Nanchang
University
Objectives: To explore change and clinical signiﬁcance of the level of plasma ho-
mocysteine (HCY) in patients with dilated cardiomyopathy (DCM).
Methods: All subjects consisted of 116 consecutively hospitalized patients with
DCM, including 92 male patients and 24 female patients, aged from 18 to 70 years
old, whose average age was (47.412.7) years old and 30 age and sex matched pa-
tients with paroxysmal supraventricular tachycardia (non-attack period, without
structural heart disease) as controls. Electrocardiogram, chest X-ray and echocardi-
ography were routinely performed, as well as thyroid function and biochemical tests,
and coronary arteriongraphy when necessary. DCM is still a diagnosis by exclusion of
hypertension, coronary heart disease, rheumatic heart disease, congenital heart dis-
ease, diabetes mellitus, arteriosclerosis, etc. Blood samples were obtained to determineardiovascular Disease Clinical Research C187
